Table 1 Baseline characteristics of study participants, January–March 2017

From: Cluster-randomized controlled trial for the early promotion of clinic visits for untreated hypertension

 

All participants

Participants with follow-up assessment

Control

(n = 142)

Intervention

(n = 145)

P value

Control

(n = 135)

Intervention

(n = 138)

P value

Male, n (%)

67 (47.2)

59 (40.7)

0.268

65 (48.2)

57 (41.3)

0.255

Age, years

50.9 (7.9)

50.3 (9.4)

0.565

50.6 (7.9)

50.0 (9.4)

0.577

Body mass index, kg/m2

25.9 (5.3)

25.3 (5.2)

0.345

25.9 (5.4)

25.4 (5.2)

0.379

Blood pressure, mmHg

  Systolic

164.7 (10.4)

164.1 (9.8)

0.623

164.6 (10.3)

164.0 (10.0)

0.631

  Diastolic

100.5 (9.3)

98.5 (8.9)

0.064

100.6 (9.4)

98.7 (9.0)

0.094

Diabetes, n (%)

10 (7.0)

8 (5.5)

0.594

8 (5.9)

8 (5.8)

0.964

Current smoker, n (%)

51 (35.9)

35 (24.1)

0.029

50 (37.0)

31 (22.5)

0.008

Daily drinker, n (%)

23 (16.2)

23 (15.9)

0.938

23 (17.0)

21 (15.2)

0.683

  1. Continuous data were analyzed with t tests and are shown as mean (standard deviation)
  2. Dichotomous data were analyzed with chi-squared tests and are shown in number (percentage)
  3. Diabetes is defined as fasting plasma glucose level ≥ 7.0 mmol/L and/or casual plasma glucose level ≥ 11.1 mmol/L, and/or HbA1c ≥ 48 mmol/mol, and/or treatment for diabetes with antidiabetic agents or insulin
Back to article page